In an international trial involving over 500 patients with impaired glucose tolerance, treatment with acarbose significantly improved glucose tolerance, and reduced the risk of progression to diabetes by 25% over 3.3 years (Chiasson 2002)
GLP-1 medications may not be suitable for individuals with: History of pancreatitis (not recommended per UK SmPCs) Severe gastrointestinal disease or gastroparesis (caution advised) Diabetic retinopathy, particularly for semaglutide (requires monitoring) Pregnancy, planning pregnancy, or breastfeeding (contraindicated
In addition to ongoing support from your clinician, youll work with a dedicated coach who can answer your questions and offer advice
Duodenal infusion of donor feces for recurrent Clostridium difficile
Michael Koehler, MD At Affinity Whole Health, we focus on evidence-based options that support skin health and healthy aging
(L)-Theanine ameliorated Rotenone-Induced Parkinsonism-like symptoms in rats